Clinical Trial Update: A Multicenter, Open-label, Single-arm, Phase II Study of NHWD-870 HCl in Adults and Adolescents with Advanced NUT Cancer [Phase 2]

View source ↗

Summary

Multicenter, open-label, single-arm Phase II trial of NHWD-870 HCl in adults and adolescents with advanced NUT carcinoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nut Carcinoma

Drugs mentioned

• NHWD-870 HCl (NHWD-870 HCl)

Snippet

Sponsor: Zhejiang Wenda Pharma Technology LTD. | Conditions: Advanced Solid Tumor (Phase 1) | Phase 2 | Status: RECRUITING